786 related articles for article (PubMed ID: 16567625)
1. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.
Mahley RW; Weisgraber KH; Huang Y
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5644-51. PubMed ID: 16567625
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology.
Mahley RW; Huang Y
Acta Neurol Scand Suppl; 2006; 185():8-14. PubMed ID: 16866905
[TBL] [Abstract][Full Text] [Related]
3. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein e sets the stage: response to injury triggers neuropathology.
Mahley RW; Huang Y
Neuron; 2012 Dec; 76(5):871-85. PubMed ID: 23217737
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
Butterfield DA; Mattson MP
Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
[TBL] [Abstract][Full Text] [Related]
6. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
7. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.
Mahley RW
J Mol Med (Berl); 2016 Jul; 94(7):739-46. PubMed ID: 27277824
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.
Ye S; Huang Y; Müllendorff K; Dong L; Giedt G; Meng EC; Cohen FE; Kuntz ID; Weisgraber KH; Mahley RW
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18700-5. PubMed ID: 16344478
[TBL] [Abstract][Full Text] [Related]
10. The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific.
Dafnis I; Argyri L; Sagnou M; Tzinia A; Tsilibary EC; Stratikos E; Chroni A
Sci Rep; 2016 Aug; 6():30654. PubMed ID: 27476701
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration.
Ji ZS; Müllendorff K; Cheng IH; Miranda RD; Huang Y; Mahley RW
J Biol Chem; 2006 Feb; 281(5):2683-92. PubMed ID: 16298992
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease.
Morrow JA; Hatters DM; Lu B; Hochtl P; Oberg KA; Rupp B; Weisgraber KH
J Biol Chem; 2002 Dec; 277(52):50380-5. PubMed ID: 12393895
[TBL] [Abstract][Full Text] [Related]
14. The interaction of amyloid-beta with ApoE.
Carter DB
Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
16. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
[TBL] [Abstract][Full Text] [Related]
17. The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.
Iurescia S; Fioretti D; Mangialasche F; Rinaldi M
J Alzheimers Dis; 2010; 21(1):35-48. PubMed ID: 20182014
[TBL] [Abstract][Full Text] [Related]
18. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
Keeney JT; Ibrahimi S; Zhao L
J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
Sanan DA; Weisgraber KH; Russell SJ; Mahley RW; Huang D; Saunders A; Schmechel D; Wisniewski T; Frangione B; Roses AD
J Clin Invest; 1994 Aug; 94(2):860-9. PubMed ID: 8040342
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells.
Ji ZS; Miranda RD; Newhouse YM; Weisgraber KH; Huang Y; Mahley RW
J Biol Chem; 2002 Jun; 277(24):21821-8. PubMed ID: 11912196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
